» Articles » PMID: 38666161

Effect of Different Doses of Dexmedetomidine As an Adjuvant to Lignocaine Nebulization: A Comparative Study During Awake Flexible Fiberoptic Bronchoscopy

Overview
Specialty Anesthesiology
Date 2024 Apr 26
PMID 38666161
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Mild to moderate sedation during bronchoscopy is essential for patient safety, comfort during and after the procedure, and to facilitate the performance of the bronchoscopist. Dexmedetomidine is a highly selective, centrally acting α-2 agonist used to provide conscious sedation during various procedures. The aim of this study was to compare the efficacy of three different doses of dexmedetomidine nebulization as an adjuvant to lignocaine during bronchoscopy.

Material And Methods: Ninety American Society of Anesthesiologists physical status I/II patients, aged from 18 to 60 years, scheduled for an elective bronchoscopy, were recruited. They were divided into three groups: 30 patients in each group. Group I: The patient was nebulized with a mixture of 4 ml of 4% lignocaine and dexmedetomidine 0.5 μg/kg. Group II: The patient was nebulized with a mixture of 4% lignocaine, 4 ml, and dexmedetomidine, 1 μg/kg. Group III: The patient was nebulized with 4% lignocaine 4 ml and dexmedetomidine 1.5 μg/kg.

Results: The mean cough score was (1.17 ± 0.37), (1.40 ± 0.49), and (1.70 ± 0.75) in group III, group II, and group I, respectively. A significant difference was found between the groups. Patients were more comfortable with a statistically significant difference in the comfort score in group III as compared to group II and group I.

Conclusion: Dexmedetomidine nebulization in a dose of 1.5 μg/kg (compared to 1 μg/kg or 0.5 μg/kg) as an adjuvant to lignocaine, provides better bronchoscopy conditions and patient satisfaction.

References
1.
Mondal S, Ghosh S, Bhattacharya S, Choudhury B, Mallick S, Prasad A . Comparison between dexmedetomidine and fentanyl on intubation conditions during awake fiberoptic bronchoscopy: A randomized double-blind prospective study. J Anaesthesiol Clin Pharmacol. 2015; 31(2):212-6. PMC: 4411836. DOI: 10.4103/0970-9185.155151. View

2.
Putinati S, Ballerin L, Corbetta L, Trevisani L, Potena A . Patient satisfaction with conscious sedation for bronchoscopy. Chest. 1999; 115(5):1437-40. DOI: 10.1378/chest.115.5.1437. View

3.
Poi P, Chuah S, Srinivas P, Liam C . Common fears of patients undergoing bronchoscopy. Eur Respir J. 1998; 11(5):1147-9. DOI: 10.1183/09031936.98.11051147. View

4.
Worsley M, Macleod A, Brodie M, Asbury A, Clark C . Inhaled fentanyl as a method of analgesia. Anaesthesia. 1990; 45(6):449-51. DOI: 10.1111/j.1365-2044.1990.tb14331.x. View

5.
Zanaty O, El Metainy S . A comparative evaluation of nebulized dexmedetomidine, nebulized ketamine, and their combination as premedication for outpatient pediatric dental surgery. Anesth Analg. 2015; 121(1):167-171. DOI: 10.1213/ANE.0000000000000728. View